Difference between revisions of "LncRNAWiki:C"
| Line 1: | Line 1: | ||
<div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
| − | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] '''C''' [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|''' | + | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] '''C''' [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']] |
</div> | </div> | ||
Revision as of 10:12, 30 June 2016
| Name | Transcript ID | Alias | Description | Disease |
|---|---|---|---|---|
| C1QTNF9B-AS1 | C1QTNF9B-AS1 | PCOTH | C1QTNF9B antisense RNA 1 | prostate cancer |
| C21orf91-OT1 | C21orf91-OT1 | D21S2089E | C21orf91 overlapping transcript 1 | _ |
| C5orf66-AS1 | C5orf66-AS1 | "CTC-276P9.1, Epist" | C5orf66 antisense RNA 1 | esophageal squamous cell carcinoma |
| C5orf66-AS2 | C5orf66-AS2 | N/A | C5orf66 antisense RNA 2 | _ |
| C8orf34-AS1 | C8orf34-AS1 | N/A | C8orf34 antisense RNA 1 | _ |
| CACNA1G-AS1 | CACNA1G-AS1 | N/A | CACNA1G antisense RNA 1 | keloid |
| CAHM | ENST00000604200.1 | LINC00468 | colon adenocarcinoma hypermethylated (non-protein coding) | colorectal neoplasia. |
| CAPN10-AS1 | CAPN10-AS1 | locus959 | CAPN10 antisense RNA 1 (head to head) | _ |
| CAR Intergenic 10 | NONHSAT016928,lnc-FANK1-3:1 | "Intergenic10, CR611911, AK055628" | Chromatin Associated RNA 10 | _ |
| CARD8-AS1 | CARD8-AS1 | LOC100505812 | CARD8 antisense RNA 1 | _ |
| CARMN | CARMN | CARMEN | cardiac mesoderm enhancer-associated non-coding RNA | _ |
| CASC11 | CASC11 | "TCONSN/A00014535, LINC00990, CARLo-7" | cancer susceptibility candidate 11 (non-protein coding) | colorectal cancer |
| CASC15 | CASC15 | N/A | cancer susceptibility candidate 15 (non-protein coding) | metastatic melanoma |
| CASC19 | CASC19 | CARLo-6 | cancer susceptibility candidate 19 (non-protein coding) | prostate cancer |
| CASC2 | CASC2 | N/A | cancer susceptibility candidate 2 (non-protein coding) | colorectal cancer |
| CASC21 | CASC21 | CARLo-2 | cancer susceptibility candidate 21 (non-protein coding) | _ |
| CASC22 | CASC22 | "TCONSN/A00024290, LincRNA-ENST00000515084" | cancer susceptibility candidate 22 (non-protein coding) | breast cancer |
| CASC8 | CASC8 | "LINC00860,CARLo-1" | cancer susceptibility candidate 8 (non-protein coding) | Colorectal Cancer,Lung Cancer |
| CASC9 | CASC9 | "LINC00981, ESCCAL-1" | cancer susceptibility candidate 9 (non-protein coding) | predicted esophageal squamous cell carcinoma |
| CBR3-AS1 | CBR3-AS1 | PlncRNA-1 | CBR3 antisense RNA 1 | esophageal squamous carcinoma cell |
| CCAT1 | NONHSAT129017 | "CARLo-5, onco-lncRNA-40" | colon cancer associated transcript 1 (non-protein coding) | colorectal cancer,gastric cancer |
| CCAT2 | CCAT2 | "NCCP1, LINC00873" | colon cancer associated transcript 2 (non-protein coding) | non-small cell lung cancer |
| CCDC18-AS1 | CCDC18-AS1 | ENST00000440778.1 | CCDC18 antisense RNA 1 | Adolescent Idiopathic Scoliosis |
| CCDC26 | CCDC26 | "MGC27434, RAM" | CCDC26 long non-coding RNA | glioma |
| CCEPR | CCEPR | CCHE1 | cervical carcinoma expressed PCNA regulatory lncRNA | cervical cancer |
| CDKN1A-AS1 | CDKN1A-AS1 | p21NAT | CDKN1A antisense RNA 1 | _ |
| CDKN2B-AS1 | NONHSAT130421,lnc-C9orf53-2:1 | "ANRIL, p15AS, ENSG00000240498" | CDKN2B antisense RNA 1 | abdominal aortic aneurysm,acute lymphoblastic leukemia,basal cell carcinoma,breast cancer,cardiovascular disease,coronary artery disease,coronary heart disease,Diabetes,endometriosis,Esophageal squamous cell cancer,gastric cancer,glioma,hereditary cutaneous malignant melanoma,intracranial aneurism,ischemic stroke,melanoma,myocardial infarction,nasopharyngeal carcinoma,neural system tumors syndrome,Neurofibromatosis type 1,periodontitis,prostate cancer, |
| CDR1-AS | CDR1-AS | "CDR1NAT, ciRS-7, CDR1as" | CDR1 antisense RNA | _ |
| CDRT7 | CDRT7 | "NCRNA00025, LINC00025" | CMT1A duplicated region transcript 7 (non-protein coding) | _ |
| CDRT8 | CDRT8 | N/A | CMT1A duplicated region transcript 8 | _ |
| CECR3 | CECR3 | N/A | "cat eye syndrome chromosome region, candidate 3 (non-protein coding)" | cat eye syndrome |
| CECR5-AS1 | CECR5-AS1 | NCRNA00017 | CECR5 antisense RNA 1 | cat eye syndrome |
| CECR7 | CECR7 | SAHL1 | "cat eye syndrome chromosome region, candidate 7 (non-protein coding)" | cat eye syndrome |
| CECR9 | CECR9 | N/A | "cat eye syndrome chromosome region, candidate 9 (non-protein coding)" | cat eye syndrome |
| CEP83-AS1 | CEP83-AS1 | N/A | CEP83 antisense RNA 1 (head to head) | _ |
| CIRBP-AS1 | CIRBP-AS1 | MGC39338 | CIRBP antisense RNA 1 | _ |
| CISTR | NONHSAT028496 | "CISTR-ACT, CISTRACT, re52431" | chondrogenesis-associated transcript | _ |
| CLRN1-AS1 | CLRN1-AS1 | UCRP | CLRN1 antisense RNA 1 | Usher syndrome type 3 |
| COPG2IT1 | COPG2IT1 | "CIT1, NCRNA00170, COPG2AS" | COPG2 imprinted transcript 1 (non-protein coding) | _ |
| CPS1-IT1 | CPS1-IT1 | "PRO0132, CPS1-IT" | CPS1 intronic transcript 1 | _ |
| CRNDE | Lnc-IRX3-4:2 | "LOC643911, LINC00180, CRNDEP" | colorectal neoplasia differentially expressed (non-protein coding) | colorectal cancer |
| CSNK1G2-AS1 | CSNK1G2-AS1 | MGC39696 | CSNK1G2 antisense RNA 1 | _ |
| CSTF3-AS1 | CSTF3-AS1 | N/A | CSTF3 antisense RNA 1 (head to head) | _ |
| CTBP1-AS | CTBP1-AS | PCAT10 | CTBP1 antisense RNA | prostate cancer |
| CTBP1-AS2 | CTBP1-AS2 | MGC21675 | CTBP1 antisense RNA 2 (head to head) | _ |
| CYP1B1-AS1 | CYP1B1-AS1 | MGC34824 | CYP1B1 antisense RNA 1 | _ |
| CYP4A22-AS1 | ENST00000444042.2 | "Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506" | CYP4A22 antisense RNA 1 | _ |
| CYP51A1-AS1 | CYP51A1-AS1 | "ENST00000453068, LRRD1-AS1" | CYP51A1 antisense RNA 1 | renal cell carcinoma |
| CYYR1-AS1 | ENST00000357401.3 | cysteine and tyrosine rich 1 antisense RNA 1 | N/A | _ |
